Takamura T - Search Results

1

LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance.

Lan F, Misu H, Chikamoto K, Takayama H, Kikuchi A, Mohri K, Takata N, Hayashi H, Matsuzawa-Nagata N, Takeshita Y, Noda H, Matsumoto Y, Ota T, Nagano T, Nakagen M, Miyamoto K, Takatsuki K, Seo T, Iwayama K, Tokuyama K, Matsugo S, Tang H, Saito Y, Yamagoe S, Kaneko S, Takamura T. Lan F, et al. Among authors: takamura t. Diabetes. 2014 May;63(5):1649-64. doi: 10.2337/db13-0728. Epub 2014 Jan 29. Diabetes. 2014. PMID: 24478397 Free article.

2

Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis.

Ando H, Takamura T, Ota T, Nagai Y, Kobayashi K. Ando H, et al. Among authors: takamura t. J Pharmacol Exp Ther. 2000 Sep;294(3):1043-6. J Pharmacol Exp Ther. 2000. PMID: 10945857

3

Preobesity in World Health Organization classification involves the metabolic syndrome in Japanese.

Ota T, Takamura T, Hirai N, Kobayashi K. Ota T, et al. Among authors: takamura t. Diabetes Care. 2002 Jul;25(7):1252-3. doi: 10.2337/diacare.25.7.1252. Diabetes Care. 2002. PMID: 12087037 No abstract available.

4

Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model.

Ota T, Takamura T, Ando H, Nohara E, Yamashita H, Kobayashi K. Ota T, et al. Among authors: takamura t. Diabetologia. 2003 Jun;46(6):843-51. doi: 10.1007/s00125-003-1099-3. Epub 2003 May 27. Diabetologia. 2003. PMID: 12774163

5

Fulminating onset type 1 diabetes with positivity for anti-GAD antibody and elevated pancreatic exocrine enzyme concentrations.

Kahara T, Takamura T, Ando H, Sakurai M, Ota T, Misaki T, Oba S, Iguchi M, Komori K, Kobayashi K. Kahara T, et al. Among authors: takamura t. Intern Med. 2003 Jun;42(6):517-20. doi: 10.2169/internalmedicine.42.517. Intern Med. 2003. PMID: 12857052 Free article.

6

Predictive value of autoantibodies to IA-2 for insulin requirements in Japanese subjects with type 1 diabetes.

Ota T, Takamura T, Bando Y, Usuda R, Nagai Y. Ota T, et al. Among authors: takamura t. Diabetes Care. 2003 Nov;26(11):3188-9. doi: 10.2337/diacare.26.11.3188. Diabetes Care. 2003. PMID: 14578263 No abstract available.

7

Effects of pravastatin on the expression of ATP-binding cassette transporter A1.

Ando H, Tsuruoka S, Yamamoto H, Takamura T, Kaneko S, Fujimura A. Ando H, et al. Among authors: takamura t. J Pharmacol Exp Ther. 2004 Oct;311(1):420-5. doi: 10.1124/jpet.104.068213. Epub 2004 Jun 21. J Pharmacol Exp Ther. 2004. PMID: 15210833

8

Genes for systemic vascular complications are differentially expressed in the livers of type 2 diabetic patients.

Takamura T, Sakurai M, Ota T, Ando H, Honda M, Kaneko S. Takamura T, et al. Diabetologia. 2004 Apr;47(4):638-47. doi: 10.1007/s00125-004-1366-y. Diabetologia. 2004. PMID: 15298340

9

Significance of IA-2 antibody in Japanese type 1 diabetes: its association with GAD antibody.

Ota T, Takamura T, Nagai Y, Bando Y, Usuda R. Ota T, et al. Among authors: takamura t. Diabetes Res Clin Pract. 2005 Jan;67(1):63-9. doi: 10.1016/j.diabres.2004.05.004. Diabetes Res Clin Pract. 2005. PMID: 15620435

10

Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.

Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T. Akahori H, et al. Among authors: takamura t. J Pharmacol Exp Ther. 2005 Aug;314(2):514-21. doi: 10.1124/jpet.105.084772. Epub 2005 Apr 27. J Pharmacol Exp Ther. 2005. PMID: 15857946

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

526 results

Search Page

Filters